Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor

被引:9
|
作者
Grovit-Ferbas, K
Ferbas, J
Gudeman, V
Sadeghi, S
Goetz, MB
Giorgi, JV
Chen, ISY
O'Brien, WA
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Microbiol & Immunol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA 90095 USA
[4] Vet Adm Med Ctr, Los Angeles, CA 90073 USA
关键词
D O I
10.1128/JVI.72.11.8650-8658.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Lack of clinical progression in some individuals despite prolonged human immunodeficiency virus type 1 (HIV-1) infection may result from infection with less-pathogenic viral strains. To address this question, we examined the IIIV-1 en;elope protein from a donor with a low viral burden, stable CD4(+) T-lymphocyte counts, and little evidence of CD8(+) T-cell expansion, activation, or immune activity. To avoid potential changes in envelope function resulting from selection in vitro, envelope clones were constructed by using viral RNA isolated from uncultured peripheral blood mononuclear cells (PBMC). The data showed that recombinant viruses containing envelope sequences derived from RNA isolated from patient PBMC replicated poorly in primary CD4(+) T cells but demonstrated efficient growth in macrophages. The unusual phenotype of these viruses could not be explained solely by differential utilization of coreceptors since the chimeric viruses, as well as an uncloned isolate obtained from the same visit date, can utilize CCR5. In addition, the donor's own cells appeared resistant to infection with chimeric viruses containing autologous envelope sequences. Genotype analysis revealed that the donor was heterozygous for the previously described 32-bp deletion in CCR5 which may be linked with prolonged survival in IIIV-1-infected individuals. These data suggest that the changes in envelope sequences confer properties of viral attenuation, which together with the CCR5 +/Delta 32 genotype could account for the long-term survival of this patient.
引用
收藏
页码:8650 / 8658
页数:9
相关论文
共 50 条
  • [31] DRUG-RESISTANCE AND HETEROGENEOUS LONG-TERM VIROLOGICAL RESPONSES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS TO ZIDOVUDINE AND DIDANOSINE COMBINATION THERAPY
    SHAFER, RW
    IVERSEN, AKN
    WINTERS, MA
    AGUINIGA, E
    KATZENSTEIN, DA
    MERIGAN, TC
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01): : 70 - 78
  • [32] Pregnancy and human herpesvirus 8 reactivation in human immunodeficiency virus type 1-infected women
    Lisco, Andrea
    Barbierato, Massimo
    Fiore, Jose R.
    Gasperini, Paola
    Favia, Anna
    Volpe, Anna
    Chironna, Maria
    Pastore, Giuseppe
    Chieco-Bianchi, Luigi
    Calabro, Maria Luisa
    JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (11) : 3863 - 3871
  • [33] Infants of Human Immunodeficiency Virus Type 1-Infected Women in Rural South India
    Read, Jennifer S.
    Samuel, N. M.
    Srijayanth, Parameshwari
    Dharmarajan, Shoba
    Van Hook, Hannah M.
    Jacob, Mini
    Junankar, Viju
    Bethel, James
    Yu, Eunice
    Stoszek, Sonia K.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (01) : 14 - 17
  • [34] Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India
    Mehendale, SM
    Bollinger, RC
    Kulkarni, SS
    Stallings, RY
    Brookmeyer, RS
    Kulkarni, SV
    Divekar, AD
    Gangakhedkar, RR
    Joshi, SN
    Risbud, AR
    Thakar, MA
    Mahajan, BA
    Kale, VA
    Ghate, MV
    Gadkari, DA
    Quinn, TC
    Paranjape, RS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (16) : 1175 - 1179
  • [35] Growth in human immunodeficiency virus type 1-infected children treated with protease inhibitors
    Steiner, F
    Kind, C
    Aebi, LC
    Wyler-Lazarevitch, CA
    Cheseaux, JJ
    Rudin, C
    Molinari, L
    Nadal, D
    EUROPEAN JOURNAL OF PEDIATRICS, 2001, 160 (10) : 611 - 616
  • [36] Low relative frequencies of CD26+ CD4+ cells in long-term nonprogressing human immunodeficiency virus type 1-infected subjects
    Brostrom, C
    Sonnerborg, A
    Lindback, S
    Gaines, H
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (05) : 662 - 666
  • [37] Culture-positive tuberculosis in human immunodeficiency virus type 1-infected children
    Schaaf, HS
    Geldenduys, A
    Gie, RP
    Cotton, MF
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (07) : 599 - 604
  • [38] Lymphocyte subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi
    Embree, J
    Bwayo, J
    Nagelkerke, N
    Njenga, S
    Nyange, P
    Ndinya-Achola, J
    Pamba, H
    Plummer, F
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (04) : 397 - 403
  • [39] Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers
    Richardson, BA
    John-Stewart, GC
    Hughes, JP
    Nduati, R
    Mbori-Ngacha, D
    Overbaugh, J
    Kreiss, JK
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (05): : 736 - 740
  • [40] Patterns of presentation of human immunodeficiency virus type 1-infected children to the paediatric surgeon
    Grant, HW
    JOURNAL OF PEDIATRIC SURGERY, 1999, 34 (02) : 251 - 254